Prevalence of C-C chemokine receptor type 5 tropism among human immunodeficiency virus 1–infected patients in South Korea

Je Eun Song, Mi Young Ahn, Woo Joo Kim, Shin Woo Kim, Jin Soo Lee, Nam Su Ku, Joon Hyung Kim, Ki Hyon Kim, Heawon Ann, JunYong Choi

Research output: Contribution to journalArticle

Abstract

Objective: The discovery of two main coreceptors for human immunodeficiency virus (HIV), C-C chemokine receptor type 5 (CCR5), and C-X-C chemokine receptor type 4 has led to a better understanding of the interaction between HIV envelope and host cells, and development of new therapeutic approaches. The purpose of this study was to estimate the prevalence of CCR5 tropism among HIV-1–infected Koreans and identify the predictors for CCR5 tropism. Methods: We enrolled 250 HIV-1–infected subjects from four medical centers of three different cities in South Korea between April 2013 and May 2014. Genotypic assay for identifying coreceptor tropism of HIV-1 was performed with HIV RNA or HIV DNA. Nested polymerase chain reaction and population-based sequencing for the V3 region (HXB2 position 6225-7758) of the envelope were performed with HIV RNA or proviral DNA. Proviral DNA was used if the viral load of the subject was below 2000 copies/mL. Genotypic tropism was determined by a web-based bioinformatics tool (http://coreceptor.bioinf.mpi-inf.mpg.de/). Results: Among 250 individuals enrolled, only 143 subjects could be analyzed for genotypic tropism assay with HIV RNA or proviral DNA. The prevalence of CCR5 tropism was 69.2% (N = 99). We could not identify any significant clinical or epidemiological predictors for CCR5 tropism among enrolled subjects. Conclusions: The prevalence of CCR5 tropism in HIV-1–infected Korean individuals was 69.2%. Since we cannot predict coreceptor tropism by clinical factors, tropism assay should be performed before treatment with the CCR5 antagonist.

Original languageEnglish
Pages (from-to)1720-1723
Number of pages4
JournalJournal of Medical Virology
Volume90
Issue number11
DOIs
Publication statusPublished - 2018 Nov 1

Fingerprint

CC Chemokines
Republic of Korea
Tropism
Chemokine Receptors
HIV
DNA
RNA
CXC Chemokines
Computational Biology
Viral Load
HIV-1

All Science Journal Classification (ASJC) codes

  • Virology
  • Infectious Diseases

Cite this

Song, Je Eun ; Ahn, Mi Young ; Kim, Woo Joo ; Kim, Shin Woo ; Lee, Jin Soo ; Ku, Nam Su ; Kim, Joon Hyung ; Kim, Ki Hyon ; Ann, Heawon ; Choi, JunYong. / Prevalence of C-C chemokine receptor type 5 tropism among human immunodeficiency virus 1–infected patients in South Korea. In: Journal of Medical Virology. 2018 ; Vol. 90, No. 11. pp. 1720-1723.
@article{bea983b548924d6198446b3c748416a7,
title = "Prevalence of C-C chemokine receptor type 5 tropism among human immunodeficiency virus 1–infected patients in South Korea",
abstract = "Objective: The discovery of two main coreceptors for human immunodeficiency virus (HIV), C-C chemokine receptor type 5 (CCR5), and C-X-C chemokine receptor type 4 has led to a better understanding of the interaction between HIV envelope and host cells, and development of new therapeutic approaches. The purpose of this study was to estimate the prevalence of CCR5 tropism among HIV-1–infected Koreans and identify the predictors for CCR5 tropism. Methods: We enrolled 250 HIV-1–infected subjects from four medical centers of three different cities in South Korea between April 2013 and May 2014. Genotypic assay for identifying coreceptor tropism of HIV-1 was performed with HIV RNA or HIV DNA. Nested polymerase chain reaction and population-based sequencing for the V3 region (HXB2 position 6225-7758) of the envelope were performed with HIV RNA or proviral DNA. Proviral DNA was used if the viral load of the subject was below 2000 copies/mL. Genotypic tropism was determined by a web-based bioinformatics tool (http://coreceptor.bioinf.mpi-inf.mpg.de/). Results: Among 250 individuals enrolled, only 143 subjects could be analyzed for genotypic tropism assay with HIV RNA or proviral DNA. The prevalence of CCR5 tropism was 69.2{\%} (N = 99). We could not identify any significant clinical or epidemiological predictors for CCR5 tropism among enrolled subjects. Conclusions: The prevalence of CCR5 tropism in HIV-1–infected Korean individuals was 69.2{\%}. Since we cannot predict coreceptor tropism by clinical factors, tropism assay should be performed before treatment with the CCR5 antagonist.",
author = "Song, {Je Eun} and Ahn, {Mi Young} and Kim, {Woo Joo} and Kim, {Shin Woo} and Lee, {Jin Soo} and Ku, {Nam Su} and Kim, {Joon Hyung} and Kim, {Ki Hyon} and Heawon Ann and JunYong Choi",
year = "2018",
month = "11",
day = "1",
doi = "10.1002/jmv.25254",
language = "English",
volume = "90",
pages = "1720--1723",
journal = "Journal of Medical Virology",
issn = "0146-6615",
publisher = "Wiley-Liss Inc.",
number = "11",

}

Prevalence of C-C chemokine receptor type 5 tropism among human immunodeficiency virus 1–infected patients in South Korea. / Song, Je Eun; Ahn, Mi Young; Kim, Woo Joo; Kim, Shin Woo; Lee, Jin Soo; Ku, Nam Su; Kim, Joon Hyung; Kim, Ki Hyon; Ann, Heawon; Choi, JunYong.

In: Journal of Medical Virology, Vol. 90, No. 11, 01.11.2018, p. 1720-1723.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prevalence of C-C chemokine receptor type 5 tropism among human immunodeficiency virus 1–infected patients in South Korea

AU - Song, Je Eun

AU - Ahn, Mi Young

AU - Kim, Woo Joo

AU - Kim, Shin Woo

AU - Lee, Jin Soo

AU - Ku, Nam Su

AU - Kim, Joon Hyung

AU - Kim, Ki Hyon

AU - Ann, Heawon

AU - Choi, JunYong

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Objective: The discovery of two main coreceptors for human immunodeficiency virus (HIV), C-C chemokine receptor type 5 (CCR5), and C-X-C chemokine receptor type 4 has led to a better understanding of the interaction between HIV envelope and host cells, and development of new therapeutic approaches. The purpose of this study was to estimate the prevalence of CCR5 tropism among HIV-1–infected Koreans and identify the predictors for CCR5 tropism. Methods: We enrolled 250 HIV-1–infected subjects from four medical centers of three different cities in South Korea between April 2013 and May 2014. Genotypic assay for identifying coreceptor tropism of HIV-1 was performed with HIV RNA or HIV DNA. Nested polymerase chain reaction and population-based sequencing for the V3 region (HXB2 position 6225-7758) of the envelope were performed with HIV RNA or proviral DNA. Proviral DNA was used if the viral load of the subject was below 2000 copies/mL. Genotypic tropism was determined by a web-based bioinformatics tool (http://coreceptor.bioinf.mpi-inf.mpg.de/). Results: Among 250 individuals enrolled, only 143 subjects could be analyzed for genotypic tropism assay with HIV RNA or proviral DNA. The prevalence of CCR5 tropism was 69.2% (N = 99). We could not identify any significant clinical or epidemiological predictors for CCR5 tropism among enrolled subjects. Conclusions: The prevalence of CCR5 tropism in HIV-1–infected Korean individuals was 69.2%. Since we cannot predict coreceptor tropism by clinical factors, tropism assay should be performed before treatment with the CCR5 antagonist.

AB - Objective: The discovery of two main coreceptors for human immunodeficiency virus (HIV), C-C chemokine receptor type 5 (CCR5), and C-X-C chemokine receptor type 4 has led to a better understanding of the interaction between HIV envelope and host cells, and development of new therapeutic approaches. The purpose of this study was to estimate the prevalence of CCR5 tropism among HIV-1–infected Koreans and identify the predictors for CCR5 tropism. Methods: We enrolled 250 HIV-1–infected subjects from four medical centers of three different cities in South Korea between April 2013 and May 2014. Genotypic assay for identifying coreceptor tropism of HIV-1 was performed with HIV RNA or HIV DNA. Nested polymerase chain reaction and population-based sequencing for the V3 region (HXB2 position 6225-7758) of the envelope were performed with HIV RNA or proviral DNA. Proviral DNA was used if the viral load of the subject was below 2000 copies/mL. Genotypic tropism was determined by a web-based bioinformatics tool (http://coreceptor.bioinf.mpi-inf.mpg.de/). Results: Among 250 individuals enrolled, only 143 subjects could be analyzed for genotypic tropism assay with HIV RNA or proviral DNA. The prevalence of CCR5 tropism was 69.2% (N = 99). We could not identify any significant clinical or epidemiological predictors for CCR5 tropism among enrolled subjects. Conclusions: The prevalence of CCR5 tropism in HIV-1–infected Korean individuals was 69.2%. Since we cannot predict coreceptor tropism by clinical factors, tropism assay should be performed before treatment with the CCR5 antagonist.

UR - http://www.scopus.com/inward/record.url?scp=85053876260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053876260&partnerID=8YFLogxK

U2 - 10.1002/jmv.25254

DO - 10.1002/jmv.25254

M3 - Article

VL - 90

SP - 1720

EP - 1723

JO - Journal of Medical Virology

JF - Journal of Medical Virology

SN - 0146-6615

IS - 11

ER -